Showing results (1411-1420 of 7,335) with videos related to

Sort By:
Pageof 734
The Journal of Pathology|October 19, 2016
CAFs and TAMs: maestros of the tumour microenvironmentYoshihiro Komohara, Motohiro Takeya
The Journal of Pathology|October 19, 2016
New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complexHilaire C Lam, Julie Nijmeh, Elizabeth P Henske
The Journal of Pathology|May 24, 2008
Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesionsJ C Sluimer, J M Gasc, I Hamming, et al.
The Journal of Pathology|February 1, 1991
Enteroviruses and idiopathic dilated cardiomyopathyH R Cochrane, F E May, T Ashcroft, et al.
The Journal of Pathology|June 5, 2008
Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPRX-H Yao, Y-F Ping, J-H Chen, et al.
The Journal of Pathology|June 7, 2008
A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formationG Vainer, E Vainer-Mosse, A Pikarsky, et al.
The Journal of Pathology|February 20, 2014
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinomaYvonne T Tsang, Michael T Deavers, Charlotte C Sun, et al.
The Journal of Pathology|December 1, 1987
Elastosis in breast carcinoma: II. Association of protease inhibitors with immature elastic fibresJ D Davies, S L Mera
The Journal of Pathology|March 12, 2014
Hyperlipidaemia impairs the circadian clock and physiological homeostasis of vascular smooth muscle cells via the suppression of Smarcd1Siyu Chen, Yan Ding, Zhao Zhang, et al.
The Journal of Pathology|March 12, 2014
Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour modelsLorenzo Melchor, Gemma Molyneux, Alan Mackay, et al.
Pageof 734